Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study is a research paper published in PLoS Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
School of Medicine, University of Alabama at Birmingham
Grant: COVID-19 Research Initiative
School of Medicine, University of Alabama at Birmingham
Grant: Cancer Immunobiology Program
National Institute of Allergy and Infectious Diseases
Grant: UM1AI069452
National Institute of Allergy and Infectious Diseases
Grant: R01AI150590
National Cancer Institute
Grant: U01CA260462
NIAID NIH HHS
Grant: R37 AI150590
NCI NIH HHS
Grant: P30 CA013148
NIAID NIH HHS
Grant: R01 AI089956
National Institutes of Health
Grant: 3U01CA260462-02S1
Adaptive Immunity and Persistent SARS-CoV-2 Replication
National Institutes of Health
Grant: 5R37AI150590-04
Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens
National Institutes of Health
Grant: 5UM1AI069452-10
Alabama Clinical Trials Unit
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals